NCT00203775终止不适用
Efficacy of Risperidone Versus Haloperidol in the Treatment of Aggression and Hostility in Psychotic Inmates
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 终止
- 试验地点
- 2
研究概览
简要总结
This study examines the efficacy of haldol versus risperdal in the treatment of aggression in psychotic prison inmates. It is hypothsized that risperdal will be more effective in decreasing aggression than haldol.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •age 18 or over, psychotic disorder diagnosed on SCID, inmate at correctional facility for at least 2 weeks -
排除标准
- •active withdrawal from substances of abuse, non-psychotic individuals, pregnant women, people unable to give informed consent, patients on mood stabilizers
研究者
研究点 (2)
Loading locations...
相似试验
已完成
3 期
A Study of the Effectiveness and Safety of Risperidone Compared With Haloperidol and Placebo in Patients With Chronic SchizophreniaPsychotic DisordersSchizophreniaNCT00249132Janssen, LP523
已完成
4 期
A Comparison of Risperidone With Haloperidol in Patients With Schizophrenia and Schizoaffective DisorderSchizophreniaSchizoaffective DisorderNCT00253110Janssen, LP396
已完成
不适用
Haloperidol and Risperidone efficacy for Attention Deficit Hyperactivity Disorder treatmentAttention deficit hyperactivity disorder.hyperkinetic disorderIRCT2015082623766N1vice chancellor for research of Ahwaz Jondishapour University of Medical Sciences46
已完成
3 期
A Study of the Effectiveness and Safety of Risperidone in the Treatment of Behavioral Disturbances in Patients With DementiaAlzheimer DiseaseDementiaVascular DementiaNCT00249158Janssen-Cilag Pty Ltd344
已完成
4 期
Oral Versus Injectable Risperidone for Treating First-Episode SchizophreniaSchizophreniaNCT00330551University of California, Los Angeles126